Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

HPV education trial aims to boost screening and vaccination among young women

NCT ID NCT07320157

Knowledge-focused Sponsor: Ufuk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study looks at whether teaching women about HPV (the virus that can cause cervical cancer) improves their knowledge and encourages them to get screened or vaccinated. Researchers will give online lessons to one group and compare their results to a group that didn't get the lessons. The study involves 64 women aged 18-35 who have never had an HPV test, vaccine, or diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

59 people

The number who actually took part.

Started

Jan 2026

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Being female * Women aged 18-35 years * Ability to speak and understand Turkish at a level sufficient to communicate with the researcher * Having the technical equipment necessary to participate in a video interview * No diagnosis of HPV positivity * Not having received the HPV vaccine * Not having undergone HPV DNA/Pap smear testing in the past 5 years * No diagnosis of cervical cancer * Voluntary willingness to participate in the study * No diagnosis of a psychiatric disorder Exclusion Criteria: * Being male * Having severe physical or cognitive impairments that prevent completing the questionnaire * Being under 18 years of age or over 35 years of age * Inability to speak or understand Turkish * Lack of technical equipment to participate in a video interview * Having a diagnosis of HPV positivity * Having received the HPV vaccine * Having undergone HPV DNA/Pap smear testing in the past 5 years * Having a diagnosis of cervical cancer * Having a diagnosed psychiatric disorder Not agreeing to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV (human papillomavirus)-associated are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV (human papillomavirus)-associated HPV immunization status

Contacts and locations

Locations

  • UfUK UNIVERSITY

    Ankara, Ankara, 06000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.